Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Long-Term Deferred Tax (2020 - 2023)

Universe Pharmaceuticals' Long-Term Deferred Tax history spans 3 years, with the latest figure at $656980.0 for Q3 2023.

  • For Q3 2023, Long-Term Deferred Tax changed N/A year-over-year to $656980.0; the TTM value through Sep 2023 reached $656980.0, changed N/A, while the annual FY2023 figure was $656980.0, N/A changed from the prior year.
  • Long-Term Deferred Tax for Q3 2023 was $656980.0 at Universe Pharmaceuticals, down from $869997.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $869997.0 in Q3 2021 and bottomed at $186537.0 in Q3 2020.
  • The 3-year median for Long-Term Deferred Tax is $656980.0 (2023), against an average of $571171.3.
  • The largest YoY upside for Long-Term Deferred Tax was 366.39% in 2021 against a maximum downside of 366.39% in 2021.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $186537.0 in 2020, then surged by 366.39% to $869997.0 in 2021, then fell by 24.48% to $656980.0 in 2023.
  • Per Business Quant, the three most recent readings for UPC's Long-Term Deferred Tax are $656980.0 (Q3 2023), $869997.0 (Q3 2021), and $186537.0 (Q3 2020).